Peripheral Stent Market Size, Share and Growth Outlook 2026: By Type (Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents), By Mode of Delivery, By Product, By End User, Companies to 2034.
The global Peripheral Stent Market size is forecast to increase from $2.04 Billion in 2026 to $3.69 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.
The Peripheral Stent market report provides detailed analysis and outlook of Peripheral Stent segments including By Type (Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Product (Peripheral Vascular Stents, Evar Stent Grafts), By End User (Hospitals, Cardiovascular Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Peripheral Stent Industry Overview
Integrated Endovascular Technologies Are Advancing Peripheral Vascular Treatment
The peripheral stent industry is evolving through the convergence of advanced lesion preparation technologies, image-guided interventions, drug delivery platforms, and digital procedural planning. Healthcare providers are increasingly adopting integrated endovascular treatment strategies that improve vessel preparation, optimize stent deployment, and enhance long-term vessel patency in patients with complex peripheral artery disease. Manufacturers are focusing on combining imaging, atherectomy, lithotripsy, embolization, drug-coated technologies, and procedural software into comprehensive treatment ecosystems that improve procedural precision and clinical outcomes.
Advanced Lesion Preparation Improves Stent Performance
A significant industry trend is the growing emphasis on effective lesion preparation before stent implantation to improve procedural success. Boston Scientific strengthened this direction by presenting pivotal clinical data for its SEISMIQ™ 4CE Intravascular Lithotripsy system during EuroPCR 2026. Recently cleared by the FDA for peripheral applications, the technology fractures heavily calcified arterial lesions before intervention, facilitating optimal stent delivery and expansion in complex peripheral artery disease. These advances demonstrate the industry's movement toward integrated treatment pathways that address challenging vascular anatomy before definitive device implantation.
Digital Imaging and Navigation Enhance Procedural Precision
Manufacturers are increasingly integrating high-resolution imaging with procedural software to improve treatment planning and intraoperative decision-making. Abbott's Ultreon™ 3.0 platform reflects this trend by combining optical coherence tomography, vessel assessment, lesion characterization, and stenting guidance within a unified digital workflow. By integrating imaging with procedural planning, these platforms support standardized interventions, improve implant positioning, and enhance long-term procedural consistency across increasingly complex peripheral vascular procedures.
Comprehensive Endovascular Portfolios Expand Treatment Options
The peripheral stent market continues to broaden through complementary endovascular technologies that support multiple stages of vascular intervention. Medtronic reported encouraging commercial performance for its Concerto Versa™ Detachable Coil system used in peripheral embolization while also presenting positive 12-month real-world outcomes for the IN.PACT™ AV drug-coated balloon, demonstrating sustained primary patency in complex patient populations. These developments illustrate the industry's shift toward comprehensive endovascular portfolios that combine embolization, vessel preparation, drug-coated technologies, imaging, and stent optimization to deliver more personalized and durable treatment strategies for peripheral vascular disease.
Peripheral Stent Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Peripheral Stent market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, B. Braun SE, W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Cordis, Alvimedica. The Peripheral Stent market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Peripheral Stent industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Peripheral Stent industry include- Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, B. Braun SE, W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Cordis, Alvimedica. The Peripheral Stent market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Peripheral Stent Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Peripheral Stent market remains one of the strongest-performing segments in the country.
The US Peripheral Stent Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Peripheral Stent market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Peripheral Stent industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Peripheral Stent markets
Canada's strong Peripheral Stent sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Peripheral Stent market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Peripheral Stent Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Peripheral Stent market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Peripheral Stent population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Peripheral Stent industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Peripheral Stent market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Peripheral Stent sales through 2034
France Peripheral Stent companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Peripheral Stent Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Peripheral Stent distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Peripheral Stent Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Peripheral Stent market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Peripheral Stent industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Peripheral Stent industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Peripheral Stent Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Peripheral Stent market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Peripheral Stent market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Peripheral Stent Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Peripheral Stent Market Segmentation
By Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-Expandable Stents
Self-Expanding Stents
By Product
Peripheral Vascular Stents
Evar Stent Grafts
By End User
Hospitals
Cardiovascular Centers
Ambulatory Surgical Centers
Leading Companies in Peripheral Stent Industry (2026)
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
B. Braun SE
W. L. Gore & Associates, Inc.
Edwards Lifesciences Corporation
AngioDynamics, Inc.
LeMaitre Vascular, Inc.
Cordis
Alvimedica
Countries Included
The Peripheral Stent market report provides detailed analysis and outlook of Peripheral Stent segments including By Type (Drug-Eluting Stents, Bare-Metal Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Product (Peripheral Vascular Stents, Evar Stent Grafts), By End User (Hospitals, Cardiovascular Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Peripheral Stent Industry Overview
Integrated Endovascular Technologies Are Advancing Peripheral Vascular Treatment
The peripheral stent industry is evolving through the convergence of advanced lesion preparation technologies, image-guided interventions, drug delivery platforms, and digital procedural planning. Healthcare providers are increasingly adopting integrated endovascular treatment strategies that improve vessel preparation, optimize stent deployment, and enhance long-term vessel patency in patients with complex peripheral artery disease. Manufacturers are focusing on combining imaging, atherectomy, lithotripsy, embolization, drug-coated technologies, and procedural software into comprehensive treatment ecosystems that improve procedural precision and clinical outcomes.
Advanced Lesion Preparation Improves Stent Performance
A significant industry trend is the growing emphasis on effective lesion preparation before stent implantation to improve procedural success. Boston Scientific strengthened this direction by presenting pivotal clinical data for its SEISMIQ™ 4CE Intravascular Lithotripsy system during EuroPCR 2026. Recently cleared by the FDA for peripheral applications, the technology fractures heavily calcified arterial lesions before intervention, facilitating optimal stent delivery and expansion in complex peripheral artery disease. These advances demonstrate the industry's movement toward integrated treatment pathways that address challenging vascular anatomy before definitive device implantation.
Digital Imaging and Navigation Enhance Procedural Precision
Manufacturers are increasingly integrating high-resolution imaging with procedural software to improve treatment planning and intraoperative decision-making. Abbott's Ultreon™ 3.0 platform reflects this trend by combining optical coherence tomography, vessel assessment, lesion characterization, and stenting guidance within a unified digital workflow. By integrating imaging with procedural planning, these platforms support standardized interventions, improve implant positioning, and enhance long-term procedural consistency across increasingly complex peripheral vascular procedures.
Comprehensive Endovascular Portfolios Expand Treatment Options
The peripheral stent market continues to broaden through complementary endovascular technologies that support multiple stages of vascular intervention. Medtronic reported encouraging commercial performance for its Concerto Versa™ Detachable Coil system used in peripheral embolization while also presenting positive 12-month real-world outcomes for the IN.PACT™ AV drug-coated balloon, demonstrating sustained primary patency in complex patient populations. These developments illustrate the industry's shift toward comprehensive endovascular portfolios that combine embolization, vessel preparation, drug-coated technologies, imaging, and stent optimization to deliver more personalized and durable treatment strategies for peripheral vascular disease.
Peripheral Stent Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Peripheral Stent market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, B. Braun SE, W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Cordis, Alvimedica. The Peripheral Stent market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Peripheral Stent industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Peripheral Stent Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Peripheral Stent companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Peripheral Stent markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Peripheral Stent industry include- Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, B. Braun SE, W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Cordis, Alvimedica. The Peripheral Stent market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Peripheral Stent Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Peripheral Stent market remains one of the strongest-performing segments in the country.
The US Peripheral Stent Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Peripheral Stent market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Peripheral Stent industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Peripheral Stent markets
Canada's strong Peripheral Stent sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Peripheral Stent market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Peripheral Stent Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Peripheral Stent market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Peripheral Stent population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Peripheral Stent industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Peripheral Stent market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Peripheral Stent sales through 2034
France Peripheral Stent companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Peripheral Stent Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Peripheral Stent distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Peripheral Stent Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Peripheral Stent market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Peripheral Stent industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Peripheral Stent industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Peripheral Stent Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Peripheral Stent market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Peripheral Stent market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Peripheral Stent Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Peripheral Stent Market Segmentation
By Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-Expandable Stents
Self-Expanding Stents
By Product
Peripheral Vascular Stents
Evar Stent Grafts
By End User
Hospitals
Cardiovascular Centers
Ambulatory Surgical Centers
Leading Companies in Peripheral Stent Industry (2026)
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
B. Braun SE
W. L. Gore & Associates, Inc.
Edwards Lifesciences Corporation
AngioDynamics, Inc.
LeMaitre Vascular, Inc.
Cordis
Alvimedica
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Peripheral Stent Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Peripheral Stent Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PERIPHERAL STENT MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Peripheral Stent Markets in 2026
3.2. Global Historic and Forecast Peripheral Stent Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Peripheral Stent Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Peripheral Stent Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Peripheral Stent Value Chain
CHAPTER 4- PERIPHERAL STENT MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Peripheral Stent Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PERIPHERAL STENT MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-Expandable Stents
Self-Expanding Stents
By Product
Peripheral Vascular Stents
Evar Stent Grafts
By End User
Hospitals
Cardiovascular Centers
Ambulatory Surgical Centers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Peripheral Stent Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Peripheral Stent Market Trends and Growth Opportunities to 2034
7.5. North America Peripheral Stent Market Size Outlook by Type
7.6. North America Peripheral Stent Market Size Outlook by Application
7.7. North America Peripheral Stent Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Peripheral Stent Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Peripheral Stent Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Peripheral Stent Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Peripheral Stent Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Peripheral Stent Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Peripheral Stent Companies
CHAPTER 8- EUROPE PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Peripheral Stent Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Peripheral Stent Market Trends and Growth Opportunities to 2034
8.5. Europe Peripheral Stent Market Size Outlook by Type
8.6. Europe Peripheral Stent Market Size Outlook by Application
8.7. Europe Peripheral Stent Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Peripheral Stent Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Peripheral Stent Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Peripheral Stent Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Peripheral Stent Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Peripheral Stent Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Peripheral Stent Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Peripheral Stent Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Peripheral Stent Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Peripheral Stent Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Peripheral Stent Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Peripheral Stent Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Peripheral Stent Companies
CHAPTER 9- ASIA PACIFIC PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Peripheral Stent Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Peripheral Stent Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Peripheral Stent Market Size Outlook by Type
9.6. Asia Pacific Peripheral Stent Market Size Outlook by Application
9.7. Asia Pacific Peripheral Stent Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Peripheral Stent Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Peripheral Stent Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Peripheral Stent Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Peripheral Stent Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Peripheral Stent Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Peripheral Stent Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Peripheral Stent Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Peripheral Stent Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Peripheral Stent Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Peripheral Stent Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Peripheral Stent Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Peripheral Stent Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Peripheral Stent Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Peripheral Stent Market Trends and Growth Opportunities to 2034
10.5. South and Central America Peripheral Stent Market Size Outlook by Type
10.6. South and Central America Peripheral Stent Market Size Outlook by Application
10.7. South and Central America Peripheral Stent Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Peripheral Stent Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Peripheral Stent Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Peripheral Stent Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Peripheral Stent Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Peripheral Stent Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Peripheral Stent Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Peripheral Stent Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Peripheral Stent Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Peripheral Stent Market Size Outlook by Type
11.6. Middle East and Africa Peripheral Stent Market Size Outlook by Application
11.7. Middle East and Africa Peripheral Stent Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Peripheral Stent Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Peripheral Stent Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Peripheral Stent Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Peripheral Stent Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Peripheral Stent Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Peripheral Stent Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Peripheral Stent Industry
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
B. Braun SE
W. L. Gore & Associates, Inc.
Edwards Lifesciences Corporation
AngioDynamics, Inc.
LeMaitre Vascular, Inc.
Cordis
Alvimedica
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Peripheral Stent Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Peripheral Stent Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL PERIPHERAL STENT MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Peripheral Stent Markets in 2026
3.2. Global Historic and Forecast Peripheral Stent Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Peripheral Stent Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Peripheral Stent Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Peripheral Stent Value Chain
CHAPTER 4- PERIPHERAL STENT MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Peripheral Stent Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- PERIPHERAL STENT MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Type
Drug-Eluting Stents
Bare-Metal Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-Expandable Stents
Self-Expanding Stents
By Product
Peripheral Vascular Stents
Evar Stent Grafts
By End User
Hospitals
Cardiovascular Centers
Ambulatory Surgical Centers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Peripheral Stent Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Peripheral Stent Market Trends and Growth Opportunities to 2034
7.5. North America Peripheral Stent Market Size Outlook by Type
7.6. North America Peripheral Stent Market Size Outlook by Application
7.7. North America Peripheral Stent Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Peripheral Stent Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Peripheral Stent Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Peripheral Stent Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Peripheral Stent Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Peripheral Stent Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Peripheral Stent Companies
CHAPTER 8- EUROPE PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Peripheral Stent Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Peripheral Stent Market Trends and Growth Opportunities to 2034
8.5. Europe Peripheral Stent Market Size Outlook by Type
8.6. Europe Peripheral Stent Market Size Outlook by Application
8.7. Europe Peripheral Stent Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Peripheral Stent Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Peripheral Stent Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Peripheral Stent Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Peripheral Stent Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Peripheral Stent Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Peripheral Stent Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Peripheral Stent Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Peripheral Stent Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Peripheral Stent Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Peripheral Stent Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Peripheral Stent Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Peripheral Stent Companies
CHAPTER 9- ASIA PACIFIC PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Peripheral Stent Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Peripheral Stent Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Peripheral Stent Market Size Outlook by Type
9.6. Asia Pacific Peripheral Stent Market Size Outlook by Application
9.7. Asia Pacific Peripheral Stent Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Peripheral Stent Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Peripheral Stent Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Peripheral Stent Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Peripheral Stent Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Peripheral Stent Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Peripheral Stent Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Peripheral Stent Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Peripheral Stent Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Peripheral Stent Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Peripheral Stent Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Peripheral Stent Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Peripheral Stent Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Peripheral Stent Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Peripheral Stent Market Trends and Growth Opportunities to 2034
10.5. South and Central America Peripheral Stent Market Size Outlook by Type
10.6. South and Central America Peripheral Stent Market Size Outlook by Application
10.7. South and Central America Peripheral Stent Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Peripheral Stent Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Peripheral Stent Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Peripheral Stent Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Peripheral Stent Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Peripheral Stent Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Peripheral Stent Companies
CHAPTER 11- MIDDLE EAST AND AFRICA PERIPHERAL STENT MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Peripheral Stent Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Peripheral Stent Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Peripheral Stent Market Size Outlook by Type
11.6. Middle East and Africa Peripheral Stent Market Size Outlook by Application
11.7. Middle East and Africa Peripheral Stent Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Peripheral Stent Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Peripheral Stent Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Peripheral Stent Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Peripheral Stent Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Peripheral Stent Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Peripheral Stent Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Peripheral Stent Industry
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
B. Braun SE
W. L. Gore & Associates, Inc.
Edwards Lifesciences Corporation
AngioDynamics, Inc.
LeMaitre Vascular, Inc.
Cordis
Alvimedica
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
